Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN) -- Ignore unavailable to you. Want to Upgrade?

To: Larry Liebman who wrote (38)	11/20/1999 12:24:00 AM
From: Biomaven	Read Replies (1) \| Respond to of 824

Larry, Actually it is even more interesting that in the examples you cite we haven't really seen the normal weakness associated with an offering - indeed sometimes quite the contrary. Don't know if it is a liquidity phenomenon (bigger = better), the result of the underwriters pounding on some institutional doors or something else, but it certainly is encouraging. Of course the examples you cite have all been pretty high quality stocks - doubt if the same thing would happen if you drop a tier or two in quality level. Peter